|
- New off-the-shelf pancreatic cancer therapy able to hunt . . .
Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs
- 7 Investigates: A game-changing pill Is giving pancreatic . . .
BOSTON (WHDH) - A powerful new pill is giving patients hope in their fight against pancreatic cancer Doctors at Dana-Farber Cancer Center say it’s a game-changing breakthrough
- New effective treatment for deadly pancreatic cancer may be . . .
Pancreatic cancer is one of the deadliest of all cancers Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%
- What’s new in pancreatic cancer research? 3 things to know . . .
What’s new in the treatment of pancreatic cancer? Pancreatic cancer researcher Shubham Pant, M D , shares three recent advances
- A Breakthrough in Pancreatic Cancer Treatment
However, the scientists found that significantly higher doses are often necessary to eradicate pancreatic tumors effectively “The duodenum is particularly vulnerable during radiation therapy for pancreatic cancer,” said Guy Yachin, co-founder and CEO of Xerient
- Progress in Pancreatic Cancer: A 2025 Update from Dr. Timothy . . .
Each year at our Hirshberg Symposium on Pancreatic Cancer, we share the latest progress in pancreatic cancer research and treatment At our 2025 Symposium, Dr Timothy Donahue, Chief of Surgical […]
- Latest Advances in Pancreatic Cancer Treatment (2025): A New . . .
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), remains one of the most lethal malignancies worldwide Its five-year survival rate is still below 10%, largely due to late diagnosis, limited effective treatments, and an immunologically "cold" tumor environment But 2025 brings a wave of innovation fueled by genomic science, immunotherapy, AI-driven diagnostics, and
- Biologists identify targets for new pancreatic cancer treatments
Pancreatic cancer has one of the lowest survival rates of any cancer — about 10 percent of patients survive for five years after their diagnosis Most pancreatic cancer patients receive a combination of surgery, radiation treatment, and chemotherapy
|
|
|